FiercePharma

Gilead's Descovy snared its PrEP data, but can it stand up to Truvada generics?

Gilead Sciences has the data it’ll need to start transitioning patients taking Truvada for PrEP over to Descovy, a drug with a longer patient life. But once Truvada generics hit, it might be a ...
FiercePharma

Gilead's converting Truvada PrEP users to Descovy faster than expected: analyst

One big task for Gilead Sciences’ HIV franchise in the coming year is to save some $2.5 billion in annual sales by switching as many PrEP patients as possible from Truvada to newly approved Descovy ...
Healthline

Descovy: How It’s Used for PrEP

Descovy (emtricitabine/tenofovir alafenamide) is a brand-name prescription drug that’s used to help prevent HIV. It’s not available as a generic drug. Descovy comes as an oral tablet. The active ...
Monthly Prescribing Reference

Descovy for PrEP Continues to Be Noninferior to Truvada, According to 96 Week Data

Descovy demonstrated continued noninferiority to Truvada for HIV pre-exposure prophylaxis and statistically significant differences over Truvada for pre-specified secondary end points. In the phase 3, ...
Nasdaq

U.S. Food and Drug Administration Approves Descovy® for HIV Pre-Exposure Prophylaxis (PrEP)

- Descovy Demonstrated Non-inferior Efficacy and an Improved Bone and Renal Safety Profile Compared with Truvada® in People at Risk for Sexually Acquired HIV Infection in a Global Phase 3 Trial - ...
Slate

Your PrEP Is Not a Status Symbol

This post is part of Outward, Slate’s home for coverage of LGBTQ life, thought, and culture. Read more here. In October, the U.S. Food and Drug Administration approved the drug Descovy to be used as a ...
Healthline

All About Descovy

Descovy is a medication used to treat HIV. It is also prescribed as PrEP (preexposure prophylaxis) to prevent HIV infection in individuals who are at risk of HIV. When used as HIV treatment, Descovy ...
Monthly Prescribing Reference

Descovy for HIV-1 PrEP Gets FDA Approval

The FDA has approved Descovy for HIV-1 pre-exposure prophylaxis (PrEP) in at-risk adults and adolescents (≥35kg) to reduce the risk of sexually acquired HIV-1 infection, excluding individuals at-risk ...
Medscape

One in Six HIV PrEP Descovy Switches May Be Unnecessary

George Froehle, PA, a primary care clinician at CentraCare in rural St. Cloud, Minnesota, has been prescribing the HIV prevention pill tenofovir disoproxil fumarate plus emtracitabine (TDF/FTC) since ...
Bay Area Reporter

FDA panel recommends new PrEP for some

A new HIV prevention option works well for gay and bisexual men and transgender women and should be approved by the Food and Drug Administration for these populations, according to an expert advisory ...
Business Wire

Gilead Canada Announces Notice of Compliance for DESCOVY® (emtricitabine, tenofovir alafenamide) for HIV Pre-Exposure Prophylaxis (PrEP)

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Gilead Sciences Canada, Inc. (Gilead Canada) today announced that Health Canada has granted a Notice of Compliance (NOC) for DESCOVY® (emtricitabine 200 mg and ...